Patent ID: 8383605

Claim:
A method of treating multiple myeloma, wherein the method comprises administering a therapeutically effective amount of an alkylphosphocholine compound having the structure of Formula II: in which, independently of one another: m, n, p, z are a whole number between 0 and 4; X is O; R is H, a straight-chain or branched (C 1 -C 17 )-alkyl group which may be saturated or unsaturated with one or two double and/or triple bonds; R 1 , R 2 are, independently of one another, H or a straight-chain or branched (C 1 -C 6 )-alkyl group, preferably methyl and ethyl, a (C 3 -C 7 )-cycloalkyl group, wherein said alkylphosphocholine is administered before and/or during treatment with at least one antimetabolite selected from the group consisting of 5-Azacytidine, 2-Mercaptopurine, 5-fluorouracil, 6-Thioguanine, Capecitabine, Cladribine, Clofarabine, Cytarabine, Decitabine, Doxifluridine, Floxuridine, Fludarabine, Forodesine, Gemcitabine, Nelarabine, Pentostatin, Sapacitabine, Thiarabine and Troxacitabine.